Pituitary adenylate cyclase-activating polypeptide modulates gastric enterochromaffin-like cell proliferation in rats.

[1]  T. Chiba,et al.  Comparison of the signal transduction pathways activated by gastrin in enterochromaffin-like and parietal cells. , 1998, Gastroenterology.

[2]  G. Sachs,et al.  Identification of gastric endocrine cells as the target sites of neuropeptides in regulation of gastric secretion by semi-quantitative RT-PCR and video imaging , 1998 .

[3]  U. Fölsch,et al.  Concentration-dependent activation of different signal transduction pathways by PACAP (1–38) in the rat pancreatic tumor cell line AR42J , 1998 .

[4]  J. Rehfeld,et al.  Impaired gastric acid secretion in gastrin-deficient mice. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[5]  V. Lelièvre,et al.  Differential expression and function of PACAP and VIP receptors in four human colonic adenocarcinoma cell lines. , 1998, Cellular signalling.

[6]  Laura H. Tang,et al.  Gastrin receptor expression and function during rapid transformation of the enterochromaffin-like cells in an African rodent , 1997, Regulatory Peptides.

[7]  E. Lindström,et al.  Neurohormonal regulation of histamine and pancreastatin secretion from isolated rat stomach ECL cells , 1997, Regulatory Peptides.

[8]  P. Hornby,et al.  Opposing effects of vasoactive intestinal polypeptide on gastric motor function in the dorsal vagal complex and the nucleus raphe obscurus of the rat. , 1997, The Journal of pharmacology and experimental therapeutics.

[9]  G. Makhlouf,et al.  Characterization of PACAP receptors and signaling pathways in rabbit gastric muscle cells. , 1997, The American journal of physiology.

[10]  A. Arimura,et al.  Hindbrain effects of PACAP on gastric motor function in the rat. , 1997, The American journal of physiology.

[11]  E. Dicicco-Bloom,et al.  Pituitary adenylate cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Rehfeld,et al.  Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor-deficient mice. , 1997, Gastroenterology.

[13]  J. Delvalle.  The stomach as an endocrine organ. , 1997, Digestion.

[14]  J. Waschek.  VIP and PACAP Receptor‐Mediated Actions on Cell Proliferation and Survival , 1996, Annals of the New York Academy of Sciences.

[15]  I. Tatsuno,et al.  Pituitary Adenylate Cyclase‐Activating Polypeptide (PACAP) Is a Neurotrophic Factor for Cultured Rat Cortical Neurons , 1996, Annals of the New York Academy of Sciences.

[16]  U. Fölsch,et al.  Pituitary adenylate-cyclase-activating polypeptide stimulates proto-oncogene expression and activates the AP-1 (c-Fos/c-Jun) transcription factor in AR4-2J pancreatic carcinoma cells. , 1996, European journal of biochemistry.

[17]  I. Modlin,et al.  Somatostatin receptor regulation of gastric enterochromaffin-like cell transformation to gastric carcinoid. , 1996, Surgery.

[18]  I. Tatsuno,et al.  Pituitary Adenylate Cyclase‐Activating Polypeptide (PACAP) Is a Regulator of Astrocytes: PACAP Stimulates Proliferation and Production of Interleukin 6 (IL‐6), but not Nerve Growth Factor (NGF), in Cultured Rat Astrocyte , 1996, Annals of the New York Academy of Sciences.

[19]  T. Moody,et al.  Differential Signaling and Immediate‐Early Gene Activation by Four Splice Variants of the Human Pituitary Adenylate CyclaseActivating Polypeptide Receptor (hPACAP‐R) , 1996, Annals of the New York Academy of Sciences.

[20]  R. Chinery,et al.  The role of transforming growth factor alpha in the enterochromaffin-like cell tumor autonomy in an African rodent mastomys. , 1996, Gastroenterology.

[21]  T. Noda,et al.  G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Günther,et al.  PACAP stimulates transcription of c-Fos and c-Jun and activates the AP-1 transcription factor in rat pancreatic carcinoma cells. , 1996, Biochemical and biophysical research communications.

[23]  I. Modlin,et al.  Neurohormonal modulation of rat enterochromaffin-like cell histamine secretion. , 1996, Gastroenterology.

[24]  G. Sharp,et al.  A Wortmannin-sensitive Signal Transduction Pathway Is Involved in the Stimulation of Insulin Release by Vasoactive Intestinal Polypeptide and Pituitary Adenylate Cyclase-activating Polypeptide (*) , 1996, The Journal of Biological Chemistry.

[25]  I. Modlin,et al.  Evidence for a regulatory role for histamine in gastric enterochromaffin-like cell proliferation induced by hypergastrinemia. , 1996, Digestion.

[26]  I. Modlin,et al.  Autoregulation of enterochromaffin-like cell histamine secretion via the histamine 3 receptor subtype. , 1996, The Yale journal of biology and medicine.

[27]  U. Akarca,et al.  Effect of PACAP on gastric acid secretion in rats , 1995, Peptides.

[28]  T. Moody,et al.  Pituitary adenylate cyclase activating peptide receptors regulate the growth of non-small cell lung cancer cells. , 1995, Cancer research.

[29]  M. Cross,et al.  Wortmannin and Its Structural Analogue Demethoxyviridin Inhibit Stimulated Phospholipase A2 Activity in Swiss 3T3 Cells , 1995, The Journal of Biological Chemistry.

[30]  G. Mellgren,et al.  Novel (Rp)-cAMPS Analogs as Tools for Inhibition of cAMP-kinase in Cell Culture , 1995, The Journal of Biological Chemistry.

[31]  J. Waschek,et al.  Differential expression of VIP/PACAP receptor genes in breast, intestinal, and pancreatic cell lines. , 1995, Cancer letters.

[32]  N. Rivard,et al.  Cell signalling pathway involved in PACAP-induced AR4-2J cell proliferation. , 1995, Cellular signalling.

[33]  I. Tatsuno,et al.  PACAP Functions as a Neurotrophic Factor a , 1994, Annals of the New York Academy of Sciences.

[34]  G. Sachs,et al.  Gastrin effects on isolated rat enterochromaffin-like cells in primary culture. , 1994, The American journal of physiology.

[35]  L. Olbe.  Therapeutic applications of vagotomy. , 1994, The Yale journal of biology and medicine.

[36]  T. Harmar,et al.  Multiple receptors for PACAP and VIP. , 1994, Trends in pharmacological sciences.

[37]  G. Bell,et al.  Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[38]  W. Scheithauer,et al.  Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors. , 1994, Cancer research.

[39]  J. Christophe,et al.  Type I receptors for PACAP (a neuropeptide even more important than VIP?). , 1993, Biochimica et biophysica acta.

[40]  Laurent Journot,et al.  Differential signal transduction by five splice variants of the PACAP receptor , 1993, Nature.

[41]  M. Li,et al.  Pituitary adenylate cyclase activating peptide and vasoactive intestinal polypeptide: differentiation effects on human neuroblastoma NB-OK-1 cells , 1993, Neuroscience Letters.

[42]  G. Sachs,et al.  Histamine secretion from rat enterochromaffinlike cells. , 1993, Gastroenterology.

[43]  S. Wank,et al.  Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Dahlström,et al.  Rapid induction of enterochromaffinlike cell tumors by histamine2-receptor blockade. , 1993, The American journal of pathology.

[45]  R. Jensen,et al.  Chief cells possess a receptor with high affinity for PACAP and VIP that stimulates pepsinogen release. , 1992, The American journal of physiology.

[46]  Modlin Im,et al.  The pathobiology of the human enterochromaffin-like cell. , 1992 .

[47]  N. Vaysse,et al.  Stimulation of rat pancreatic tumoral AR4-2J cell proliferation by pituitary adenylate cyclase-activating peptide. , 1992, Gastroenterology.

[48]  J. Holst,et al.  Vagal control of the release of somatostatin, vasoactive intestinal polypeptide, gastrin-releasing peptide, and HCl from porcine non-antral stomach. , 1992, Scandinavian journal of gastroenterology.

[49]  I. Tatsuno,et al.  Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosolic free calcium concentration in cultured rat hippocampal neurons. , 1992, Endocrinology.

[50]  Y. Sun,et al.  The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. , 1992, The Journal of biological chemistry.

[51]  A. Arimura.  Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research , 1992, Regulatory Peptides.

[52]  E. Dicicco-Bloom,et al.  Pituitary adenylate cyclase activating polypeptide (PACAP) potently stimulates mitosis, neuritogenesis and survival in cultured rat sympathetic neuroblasts , 1992, Regulatory Peptides.

[53]  S. Koh,et al.  VIP stimulates proliferation and differentiation of the cultured retinal pigment epithelium with disparate potencies. , 1992, Cell biology international reports.

[54]  F. Sundler,et al.  Pituitary adenylate cyclase activating peptide: A novel vasoactive intestinal peptide-like neuropeptide in the gut , 1992, Neuroscience.

[55]  T. Watanabe,et al.  Pituitary adenylate cyclase activating polypeptide provokes cultured rat chromaffin cells to secrete adrenaline. , 1992, Biochemical and biophysical research communications.

[56]  F. Sundler,et al.  Unilateral vagal denervation suppresses omeprazole-induced trophic effects on the denervated side of the rat stomach. , 1992, Scandinavian journal of gastroenterology.

[57]  S. Ohashi,et al.  Pituitary adenylate cyclase activating polypeptide stimulates insulin release from the isolated perfused rat pancreas. , 1992, Life sciences.

[58]  A. Arimura,et al.  Effect of pituitary adenylate cyclase activating polypeptide on rat pancreatic exocrine secretion , 1991, Peptides.

[59]  J. Fahrenkrug,et al.  Expression of preproVIP-derived peptides in the human gastrointestinal tract: a biochemical and immunocytochemical study , 1991, Regulatory Peptides.

[60]  E. Scholar,et al.  Stimulation of tumor cell growth by vasoactive intestinal peptide , 1991, Cancer.

[61]  N. Minamino,et al.  Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). , 1990, Biochemical and biophysical research communications.

[62]  I. Black,et al.  Vasoactive intestinal peptide regulation of neuroblast mitosis and survival: role of cAMP , 1990, Brain Research.

[63]  M. Culler,et al.  Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. , 1989, Biochemical and biophysical research communications.

[64]  A. Haegerstrand,et al.  Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[65]  J. Fahrenkrug.  VIP and autonomic neurotransmission. , 1989, Pharmacology & therapeutics.

[66]  J. Marvaldi,et al.  Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells. , 1988, The Journal of biological chemistry.

[67]  S. Ito,et al.  Gastric vasodilatation and vasoactive intestinal peptide output in response to vagal stimulation in the dog. , 1988, The Journal of physiology.

[68]  T. Moody,et al.  High affinity binding of VIP to human lung cancer cell lines , 1987, Peptides.

[69]  M. Mitsuhashi,et al.  The mitogenic effects of vasoactive neuropeptides on cultured smooth muscle cell lines. , 1987, Life sciences.

[70]  S. Said,et al.  Characterization of receptors for vasoactive intestinal peptide solubilized from the lung. , 1987, The Journal of biological chemistry.

[71]  D. Bataille,et al.  Functional receptors for VIP, GIP, Glucagon-29 and -37 in the HGT-1 human gastric cancer cell line , 1986, Peptides.

[72]  P. Ganz,et al.  Vasoactive intestinal peptide: vasodilatation and cyclic AMP generation. , 1986, The American journal of physiology.

[73]  F. Sundler,et al.  Gastrin and the trophic control of gastric mucosa. , 1986, Scandinavian journal of gastroenterology. Supplement.

[74]  L Ekman,et al.  Toxicological studies on omeprazole. , 1985, Scandinavian journal of gastroenterology. Supplement.

[75]  E. Hollande,et al.  Presence of VIP receptors in a human pancreatic adenocarcinoma cell line. Modulation of the cAMP response during cell proliferation. , 1983, Biochemical and biophysical research communications.

[76]  S. Bloom,et al.  Experimental evidence for vasoactive intestinal peptide as the cause of the watery diarrhea syndrome , 1978 .

[77]  S. Said,et al.  Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa. , 1974, The Journal of clinical investigation.